Jodi M Carter

5PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 22, 2025
Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative, Early-Stage Breast Cancer.

Aziza Nassar, Jodi Carter, Paige Innis

|Apr 03, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.

Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter

|Jan 09, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013.

Amy C Degnim, Karthik Ghosh, Robert A Vierkant

|May 24, 2023
Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.

Amy C Degnim, Brittany L Siontis, Safia K Ahmed

|Dec 05, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer.

Lixuan Wei, Huanyao Gao, Jia Yu

Pageof 1

Frequent Collaborators

2 joint publications

Tanya L Hoskin

2 joint publications

Amy C Degnim

1 joint publications

Jennifer Racz

1 joint publications

Matthew Petitt